Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa

Pseudomonas aeruginosa in cystic fibrosis: Pathogenesis and new treatments

(2014) Rossa E Brugha et al.   BRITISH JOURNAL OF HOSPITAL MEDICINE

Inhibition of Bacterial Biofilm Formation and Swarming Motility by a Small Synthetic Cationic Peptide

(2012) César de la Fuente-Núñez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia

(2012) Arianna Pompilio et al.   BMC MICROBIOLOGY

Therapeutic Potential of Host Defense Peptides in Antibiotic-resistant Infections

(2012) Nicole J. Afacan et al.   CURRENT PHARMACEUTICAL DESIGN

Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens

(2012) Chiara Falciani et al.   PLoS One

Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action

(2011) Maria Luisa Mangoni et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Multifunctional cationic host defence peptides and their clinical applications

(2011) Amy T. Y. Yeung et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Pseudomonas aeruginosa: all roads lead to resistance

(2011) Elena B.M. Breidenstein et al.   TRENDS IN MICROBIOLOGY

The clinical impact of bacterial biofilms

(2011) Niels Høiby et al.   International Journal of Oral Science

Anti-Pseudomonas Activity of Frog Skin Antimicrobial Peptides in a Caenorhabditis elegans Infection Model: a Plausible Mode of Action In Vitro and In Vivo

(2010) D. Uccelletti et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening

(2010) Joe J Harrison et al.   Nature Protocols

Pseudomonas aeruginosaMicroevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted Virulence

(2009) Alessandra Bragonzi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Temporins and their synergism against Gram-negative bacteria and in lipopolysaccharide detoxification

(2009) Maria Luisa Mangoni et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo

(2009) Alessandro Pini et al.   FASEB JOURNAL

Esculentin-1b(1-18) - a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli

(2009) Ludovica Marcellini et al.   FEBS Journal

Esculentin 1-21: a linear antimicrobial peptide from frog skin with inhibitory effect on bovine mastitis-causing bacteria

(2009) Alfonso Enrique Islas-Rodrìguez et al.   JOURNAL OF PEPTIDE SCIENCE

Pseudomonas aeruginosabiofilms in the respiratory tract of cystic fibrosis patients

(2009) Thomas Bjarnsholt et al.   PEDIATRIC PULMONOLOGY

Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease

(2008) Gerd Döring et al.   CELLULAR MICROBIOLOGY

Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation

(2008) J. Overhage et al.   INFECTION AND IMMUNITY

In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures

(2008) Marie Tré-Hardy et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Reflections on a systematic nomenclature for antimicrobial peptides from the skins of frogs of the family Ranidae

(2008) J. Michael Conlon   PEPTIDES

Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates

(2007) Elke Peeters et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway

(2007) Sophie Moreau-Marquis et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS